VSTM (Verastem, Inc.) Stock Financials & Earnings | Market Cap Arena

VSTM (Verastem, Inc.) Stock Financials & Earnings | Market Cap Arena

VSTMVerastem, Inc.

Mkt Cap$388M

Healthcare·Biotechnology·🇺🇸 United States·NASDAQ

Revenue (TTM)$31M

Net Income (TTM)-$209M

EPS (TTM)-$3.32

Free Cash Flow (TTM)-$138M

Gross Margin83.8%

Op. Margin-550.3%

Net Margin-677.6%

FCF Margin-444.8%

P/S Ratio (TTM)12.6x

P/E Ratio (TTM)—

YoY Rev Growth+209.1%

Employees—

Earnings Reports

Revenue & Profitability

Quarter	Revenue	Gross Profit	Op. Income
Q1 23	$0	$0	-$19M
Q2 23	$0	$0	-$20M
Q3 23	$0	$0	-$21M
Q4 23	$0	$0	-$31M
Q1 24	$0	$0	-$28M
Q2 24	$10M	$10M	-$18M
Q3 24	$0	$0	-$37M
Q4 24	$0	$0	-$32M
Q1 25	$0	$0	-$44M
Q2 25	$2M	$2M	-$44M
Q3 25	$11M	$10M	-$41M
Q4 25	$18M	$15M	-$41M

Valuation

Quarter	P/S	P/E
Q1 23	—	—
Q2 23	—	—
Q3 23	—	—
Q4 23	—	—
Q1 24	—	—
Q2 24	38.8x	—
Q3 24	38.8x	—
Q4 24	38.8x	—
Q1 25	38.8x	—
Q2 25	181.8x	—
Q3 25	29.0x	—
Q4 25	12.6x	—

Operating Cash Flow

Quarter	Operating CF	Free CF
Q1 23	-$20M	-$20M
Q2 23	-$20M	-$20M
Q3 23	-$17M	-$17M
Q4 23	-$30M	-$30M
Q1 24	-$28M	-$28M
Q2 24	-$28M	-$28M
Q3 24	-$24M	-$24M
Q4 24	-$25M	-$25M
Q1 25	-$39M	-$39M
Q2 25	-$33M	-$33M
Q3 25	-$36M	-$36M
Q4 25	-$30M	-$30M

Capital Expenditures

CapEx

Quarter	CapEx
Q1 23	$0
Q2 23	$0
Q3 23	$0
Q4 23	$0
Q1 24	$21K
Q2 24	$7K
Q3 24	$0
Q4 24	$0
Q1 25	$0
Q2 25	$0
Q3 25	$0
Q4 25	$0

OpEx vs Revenue Growth (YoY)

Quarter	Revenue Growth	OpEx Growth
Q1 23	-100.0%	-1.2%
Q2 23	—	-5.2%
Q3 23	—	+20.3%
Q4 23	—	+84.8%
Q1 24	—	+45.1%
Q2 24	—	+39.4%
Q3 24	—	+73.8%
Q4 24	—	+1.4%
Q1 25	—	+57.4%
Q2 25	-78.6%	+62.3%
Q3 25	—	+40.3%
Q4 25	—	+86.8%

Stock-Based Compensation

Quarter	SBC ($)	% of Revenue
Q1 23	$1M	—
Q2 23	$1M	—
Q3 23	$2M	—
Q4 23	$2M	—
Q1 24	$1M	—
Q2 24	$2M	19.1%
Q3 24	$2M	—
Q4 24	$2M	—
Q1 25	$2M	—
Q2 25	$3M	159.7%
Q3 25	$2M	19.4%
Q4 25	$2M	11.5%

OpEx Breakdown

Quarter	R&D	SG&A
Q1 23	$12M	$7M
Q2 23	$13M	$7M
Q3 23	$14M	$7M
Q4 23	$23M	$9M
Q1 24	$18M	$10M
Q2 24	$18M	$10M
Q3 24	$25M	$12M
Q4 24	$21M	$11M
Q1 25	$29M	$15M
Q2 25	$25M	$21M
Q3 25	$29M	$21M
Q4 25	$32M	$24M

Revenue Segments

Quarter

War Chest

Quarter	Cash	Short-term Investments	Total
Q1 23	$97M	$14M	$111M
Q2 23	$183M	$0	$183M
Q3 23	$95M	$71M	$166M
Q4 23	$78M	$59M	$137M
Q1 24	$81M	$29M	$110M
Q2 24	$83M	$0	$83M
Q3 24	$113M	$0	$113M
Q4 24	$89M	$0	$89M
Q1 25	$118M	$0	$118M
Q2 25	$164M	$0	$164M
Q3 25	$138M	$0	$138M
Q4 25	$205M	$0	$205M

Shares Outstanding

Shares Outstanding

Quarter	Shares (Diluted)	QoQ Change
Q1 23	17M	-1.9%
Q2 23	18M	+6.0%
Q3 23	27M	+51.1%
Q4 23	27M	+0.1%
Q1 24	27M	+0.1%
Q2 24	27M	+0.1%
Q3 24	40M	+49.9%
Q4 24	38M	-5.6%
Q1 25	54M	+42.6%
Q2 25	74M	+36.7%
Q3 25	73M	-1.2%
Q4 25	83M	+14.0%

Revenue Per Employee

Revenue / Employee

Year	Revenue/Employee	Employees
FY 14	$0	47
FY 15	$0	22
FY 16	$0	32
FY 17	$0	69
FY 18	$158K	169
FY 19	$129K	135
FY 20	$2M	48
FY 21	$43K	48
FY 22	$46K	57
FY 23	$0	73
FY 24	$128K	78
FY 25	$461	67K